slides · global inventory
Monroes Sequence
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 33,236
Current window 23,911-23,940
Pages 1,108
Rows per page 30
Arc
23,911-23,940 of 33,236
02
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Attention1 hit
03
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Attention1 hit
04
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Attention1 hit
05
The slide uses a Gantt-style visualization to show the progress of various drug candidates through clinical phases.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Need1 hit
06
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Need1 hit
07
Includes a cytogenetic map showing the 600kb deletion region on chromosome 3.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · NeedLoop · Golden Circle1 hit
08
Uses a 'brake pedal' analogy to explain biological function.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · NeedLoop · Golden Circle1 hit
09
The slide uses a process diagram to illustrate the mechanism of action for REQORSA gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · NeedLoop · Golden Circle1 hit
10
The process is presented as a sequential workflow.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
11
The slide uses a hub-and-spoke visual metaphor to connect the central platform to three key value propositions.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
12
The slide uses a numbered list format to explain the mechanism of action.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
13
The slide uses a line chart (Seahorse XF Glycolysis Stress Test profile) and a bar chart to show metabolic impact.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
14
The slide uses a series of circles to present key metrics, highlighting the global market size as the central focus.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
15
ONC-001 TrialGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
16
The slide uses fluorescence microscopy images to show the mechanism of action (selective uptake) of the drug.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
17
The trial met Simon 2-stage criteria but was discontinued to prioritize a study with Tagrisso.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
18
The slide uses a 'problem-solution' framing, highlighting the limitation of existing drugs and the mechanism of the company's therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
The slide includes a timeline of the study and two line charts showing tumor volume over time for different treatment groups.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide outlines a multi-phase clinical trial structure (Phase 1, 2a, 2b) and provides specific patient counts and interim analysis milestones.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
Includes a table of enrollment/DLTs and a swimmer plot for PFS.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
22
Includes a histological image showing negative TUSC2 expression.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
23
The table highlights a statistically significant difference (p=0.0008) in TUSC2 protein expression between SCLC and NSCLC.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
24
Includes Kaplan-Meier curves for Overall Survival (A) and Progression-free Survival (B).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
25
Kaplan-Meier survival curve showing PFS. Mentions Tecentriq as brand name for Atezolizumab.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
26
Includes bioluminescence imaging and quantitative bar chart with statistical significance markers (p-values).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
27
The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
28
Clinical trial design slide for a pharmaceutical study.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
29
The chart shows statistical significance (p-values) comparing treatment groups against controls.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
31
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit